Willis Johnson & Associates Inc. Purchases 92 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Willis Johnson & Associates Inc. increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.1% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 629 shares of the healthcare conglomerate’s stock after buying an additional 92 shares during the period. Willis Johnson & Associates Inc.’s holdings in UnitedHealth Group were worth $311,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. CGC Financial Services LLC lifted its holdings in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $31,000. LFA Lugano Financial Advisors SA lifted its holdings in shares of UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares during the last quarter. Finally, Red Tortoise LLC raised its position in UnitedHealth Group by 45.1% in the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock worth $36,000 after purchasing an additional 23 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $489.89 on Friday. The firm has a market cap of $450.89 billion, a P/E ratio of 29.94, a P/E/G ratio of 1.44 and a beta of 0.60. The firm’s 50 day moving average price is $498.61 and its 200-day moving average price is $500.96. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.26 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. The ex-dividend date was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.71%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Barclays lifted their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Finally, StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, June 28th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.